Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation.

Author: BernerTodd, CampbellJohn C, SilbersteinStephen D, TobinJohn, XiangQinfang

Paper Details 
Original Abstract of the Article :
OBJECTIVE: This post hoc subgroup analysis evaluated scheduled short-term preventive frovatriptan therapy for women with migraine occurring exclusively in association with menstruation (occurring day -2 to +3; day 1 = menses start, no migraines outside this window). BACKGROUND: A previously publish...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/j.1526-4610.2009.01509.x

データ提供:米国国立医学図書館(NLM)

Conquering Menstrual Migraines: A New Oasis of Relief

The world of migraine headaches can be a challenging desert, with unpredictable and often debilitating symptoms. For women who experience migraines specifically linked to their menstrual cycle, the struggle can feel particularly overwhelming. This study, like a compassionate camel offering a respite from the harsh desert conditions, explores the effectiveness of a scheduled short-term preventive treatment with frovatriptan for menstrual migraines.

Frovatriptan: A Beacon of Hope for Menstrual Migraines

The study's findings are like discovering a hidden oasis in the desert, offering a promising solution for women suffering from menstrual migraines. The results showed that frovatriptan, when administered on a scheduled preventative regimen, significantly reduced the occurrence of menstrual migraines, offering a sense of relief and predictability for women who experience these debilitating headaches. This discovery is a testament to the power of personalized treatment approaches, tailoring therapy to the specific needs of individual patients.

Navigating the Desert of Menstrual Migraines with Confidence

This research provides a valuable resource for women struggling with menstrual migraines, offering a new avenue for managing their condition. By understanding the effectiveness of frovatriptan as a preventative treatment, women can work with their healthcare providers to create a personalized management plan, allowing them to navigate the desert of migraines with confidence and control.

Dr.Camel's Conclusion

This study offers a ray of hope for women facing the challenge of menstrual migraines. Frovatriptan, like a friendly camel guiding weary travelers through the desert, provides a potential solution for reducing the occurrence of these debilitating headaches. This research underscores the importance of seeking personalized treatment options, empowering women to take control of their health and navigate the desert of migraines with greater confidence and ease.

Date :
  1. Date Completed 2010-01-08
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

19751371

DOI: Digital Object Identifier

10.1111/j.1526-4610.2009.01509.x

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.